Risankizumab outperforms secukinumab at one year
A phase 3b study investigating the efficacy and safety of risankizumab compared to secukinumab showed…
Pubblicazioni
A phase 3b study investigating the efficacy and safety of risankizumab compared to secukinumab showed…
